Afsaneh Mojtabanezhad Shariatpanahi1,2, Hassan Ahmadnia3, Adam Torkamanzehi1, Mahnaz Mansouri Torshizi4, Mohammad Amin Kerachian2,5. 1. Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran. 2. Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. 3. Department of Urology, Ghaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran. 4. Novin Infertility Center, Mashhad, Iran. 5. Department of Medical Genetics, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: kerachianma@mums.ac.ir.
Y chromosome is the shortest chromosome in the human
genome. It has the least number of genes among all human
chromosomes (1). The human Y chromosome is necessary
for human sex determination, and male germ cell development
and maintenance (2). Of the 60 Mb length of the Y
chromosome, 3 Mb belongs to pseudoautosomal regions
(PAR1 and PAR2 on the Yp and Yq respectively) and 57 Mb
to a nonrecombining region (NRY). The NRY region can be
classified to heterochromatic and euchromatic regions. The
euchromatin contains all of the known genes in the Y chromosome.
The euchromatic regions on the Y are about 23 Mb
consisting of 8 Mb on the short arm and 14.5 Mb on the
long arm (1, 3). Genes located on the euchromatic region of
the proximal long arm of the Y chromosome (Yq11), named
azoospermia factor (AZF) region, plays an essential role in
spermatogenesis (4, 5). Recent studies have suggested that
the AZF region cause male infertility and also recurrent pregnancy
loss when it is disrupted (6, 7).
Y Chromosome and male infertility
Approximately 15 percent of couples are infertile with the
male factor being responsible for approximately 50% of the cases. It is defined as a multifactorial syndrome encompassing
a wide variety of disorders (8). In about 50-60% of male
infertility cases, the etiology can be identified, however,
when the cause is unknown, it is referred to as idiopathic
infertility (9). A significant proportion of idiopathic male infertility
is associated with azoosperima or severe oligozoospermia,
which may be due to genetic alterations. Nevertheless,
the underlying etiology is still poorly understood (10).Recent studies have shown that both genetic and environmental
factors are involved in the reduction of reproductivity
in males. The main genetic factors in male infertility are
Y chromosomal microdeletions within the Yq11 region and
somatic chromosomal abnormalities. After Klinefelter syndrome,
Y chromosomal microdeletion is the most frequent
cause of male infertility (11) and the second most frequent
genetic cause of spermatogenic failure (12). The microdeletions
in the AZF region occur in infertile men (13). Studies
have shown that the AZF region is deleted in about 13% of
men with non-obstructive azoospermia and in 7 to 10% of
men with oligozoospermia (14). Testicular tissue sections of
azoospermic men with these Yq11 aberrations showed intense
spermatogenesis disruption. This suggested that there
is an essential function of AZF for differentiation and proliferation
of human male germ cells (15). The AZF region
consists of four sub-regions, namely AZFa, AZFb, AZFc and
AZFd (14, 16, 17). Each of these regions are associated with
a particular testicular histology, and a number of candidate
genes have been found within these regions (13). Deletions
in the AZF region occur as six classical types of Yq deletions
consist of AZFa, AZFb, AZFc, AZFbc, AZFabc and partial
AZFc (3) as described in Table 1.Genotype-phenotype correlation of AZF regions (3, 18)AZF; Azoospermia factor and SCOS; Sertoli cell-only syndrome.
Y Chromosome and recurrent pregnancy loss
Recurrent pregnancy loss (RPL), recurrent miscarriage or
habitual abortion is the occurrence of three or more consecutive
pregnancies that terminate through miscarriage before
fetus viability (for instance, 24 weeks of gestation). About
1% of couples trying to have children are affected by recurrent
miscarriage (19). RPL is a multifactorial condition with
several etiologic factors including genetic abnormalities of
the parents, endocrinologic, anatomic, hematologic and immunologic
abnormalities along with nutritional, infectious
and environmental factors (20, 21). The most commonly accepted
etiology of RPL is maternal, however, most cases are
classified as idiopathic, with no identifiable cause in either
partner (20, 22). The repetitive pregnancy loss in some couples
plus the high percentage of idiopathic RPL indicate that
the underlying causes of RPL needs to be investigated (23).
Mutations including small deletions, duplications and substitutions
cannot be detected by cytogenetic analysis. These
genetic abnormalities may thus account for a large number
of miscarriages with unknown causes (24).New evidence indicates that male factors may play a major
role in RPL (25). Sperm integrity is required for fertilization,
sperm-egg interactions and early embryonic development.
Sperm quality affects the ability of the embryo to reach the
blastocyst phase and develop into implantation. Paternally
expressed genes control the proliferation and invasiveness
of trophoblast cells, and also placental proliferation (7). The
cause of pregnancy loss in approximately 50% of women
with RPL remains unexplained despite many investigations
(26). Recent studies have shown there is a potential connection
between deletions of the AZF region and RPL (7, 26,
27). In a study by Dewan et al. (7), analysis of male partners
in couples with RPL showed 82% of the men had at least one
AZF microdeletion. Studying Y microdeletion is thus crucial
in understanding and predicting the outcome of future pregnancies,
and making informed decisions regarding treatment
such as assisted reproductive technology (ART). Therefore,
the aim of this study was to detect Y chromosomal microdeletions
in men with non-obstructive infertility and in men
having spouses with RPL by using a multiplex PCR design.
Materials and Methods
This was a case-control study. It consisted of three groups.
The first group comprised 40 infertile men (azoospermic and
severe oligozoospermic) aged 20-53 years old, who were referred
to the Ghaem General Hospital and Novin Infertility
Clinic in Mashhad, Iran, between September 2012 and September
2013. All patients in this group had primary infertility
with normal karyotype and absence of obstructive azoospermia.
The second group consisted of 20 men aged 17-42
years from couples with history of three or more consecutive
idiopathic miscarriages, all of whom were referred from the
High Education Center of Jahad Daneshgahi, Mashhad, Iran,
from 2011 to 2013. In this group all men and their spouses
had a normal karyotype. Other causes of pregnancy loss including
infectious disease, and psychological, uterine anatomic
and endocrine disorders along with immunologic and
haemostatic changes were excluded. A group of 20 healthy
men aged 25-42 years from couples with at least one live
birth and no history of miscarriage was considered as the
control group (third group).
Statistical analysis
Differences in microdeletion frequency were examined by two-tailed unpaired t test. A P<0.05 was considered
statistically significant. Demographic data of the patient
and control groups were also analyzed. All the above were
computed using the SPSS-V11 software. Our study was approved
by the Ethics Committee of Mashhad University of
Medical Sciences. An informed consent was obtained from
each individual participating in this study.
Y microdeletion multiplex polymerase chain reaction
detection assay
Genomic DNA was extracted from 3 ml of peripheral
blood lymphocyte samples using a standard salting-out
method. Isolated DNA was stored at -20°C. Following
DNA extraction, AZF microdeletions were screened by
multiplex polymerase chain reaction (PCR). Nineteen sequence-
tagged sites (STSs) within the long arm of the Y
chromosome were selected to cover AZFa, b, c and proximal
AZFc (AZFd) regions. For each participant, 18 STS in
AZFa (sY81, sY86, sY182), AZFb (sY121, sY124, sY127,
sY128, sY130, sY133, sY134, SYPR3), AZFc (sY157, sY208,
sY242, sY254, sY255) and AZFd (sY145, sY152) sub-region
were typed. The primers were combined into five sets for
multiplex PCR for the purpose of determining the presence
of all 19 sequence-tagged sites by performing five parallel
PCR amplifications from multiplex A to E.Multiplex reaction A amplified SY81, SY130, SY157,
SY182, SY254, B amplified SYPR3, SY127, SY208, SY242, C
amplified SY121, SY128, SY145, SY255, D amplified SY124,
SY133, SY152, SMCX and E amplified SY14(SRY) SY86,
SY134 ZFX/Y. Multiplex D contained a control primer pair
amplifying a fragment of the X-linked SMCX locus and multiplex
E contained a control primer pair amplifying a unique
region present on both the Y and X chromosomes (Zinc
Finger Protein of Y and X chromosomes ZFX/ZFY). These
control primer pairs were used as internal controls to check
amplification of DNA and also the integrity of the genomic
DNA sample used. Finally, the multiplex E reaction included
a primer pair amplifying a region of SRY (sex-determining region
of the Y). The presence of the short arm of the Y chromosome
(Yp) was tested with STS SY14, located within SRY. The
SRY was examined to confirm the sex of the sample donor.PCR was carried out in a total volume of 15 μl containing
150 ng of genomic DNA, 1X PCR buffer, 2 mM of MgCl2,
1 unit of Taq DNA polymerase (Genet Bio, South Korea),
0.2 mM of dNTP mix and 4 pmol of each primer. The cycling
conditions were an initial denaturation at 95°C for
5 minutes, followed by 35 cycles of denaturation at 95°C
for 30 seconds, annealing for 30 seconds at 59°C in multiplex
A, at 57°C in multiplex B and at 56°C in multiplex
reactions C, D, E, and extension at 72°C for 35 seconds,
followed by a last extension at 72°C for 5 minutes and a
cooling step at 4°C. The PCR products were separated on a
3.5% agarose gel using 1X TAE. PCR bands were visualized
using DNA Green Viewer and under ultraviolet light.
Results
No microdeletion in the AZFa, AZFb, AZFc and AZFd sub-regions was observed in male partners of women with
RPL (Fig .1) and men in the control group (Fig .2). Among
the 40 infertile men, only one subject (2.5%) had microdeletions
in multiplex reactions A and C, indicative of a
microdeletion in the AZFc region (Fig .3A, B). AZF microdeletion
was neither significantly associated with nonobstructive
infertility (P=0.48) nor with RPL.
Fig.1
Results of the multiplex reactions A, B, C, D and E in male partners
of women with recurrent pregnancy loss (RPL). Polymerase chain reaction
(PCR) fragments were separated on a 3.5% agarose gel. Lane 1; Multiplex A,
Lane 2; Multiplex B, Lane 3; Multiplex C, Lane 4; Multiplex D, and Lane 5;
Multiplex E. Molecular weight marker (50 bp ladder).
Fig.2
Results of the multiplex A, B, C, D and E in control group. Polymerase
chain reaction (PCR) fragments were separated on 3.5% agarose gel. Lane
1; Multiplex A, Lane 2; Multiplex B, Lane 3; Multiplex C, Lane 4; Multiplex D,
and Lane 5; Multiplex E. Molecular weight marker (50 bp ladder).
Fig.3
Detection of partial AZFc deletion in an infertile male patient. A. The microdeletions observed were in Multiplex A (SY254 and
SY157) and B. In Multiplex C (SY255). Polymerase chain reaction (PCR) fragments were separated on a 3.5% agarose gel. Lane 1; Fertile
control, Lane 2; Infertile man, and Lane 3; Negative control. Multiplex A reaction contained SY81 (209 bp), SY130 (173 bp), SY157 (290
bp), SY182 (125 bp) and SY254 (380 bp), and multiplex C reaction contained SY121 (190 bp), SY128 (228 bp),
SY145 (143 bp) and SY255
(124 bp). Molecular weight marker (50 bp ladder).
Results of the multiplex reactions A, B, C, D and E in male partners
of women with recurrent pregnancy loss (RPL). Polymerase chain reaction
(PCR) fragments were separated on a 3.5% agarose gel. Lane 1; Multiplex A,
Lane 2; Multiplex B, Lane 3; Multiplex C, Lane 4; Multiplex D, and Lane 5;
Multiplex E. Molecular weight marker (50 bp ladder).Results of the multiplex A, B, C, D and E in control group. Polymerase
chain reaction (PCR) fragments were separated on 3.5% agarose gel. Lane
1; Multiplex A, Lane 2; Multiplex B, Lane 3; Multiplex C, Lane 4; Multiplex D,
and Lane 5; Multiplex E. Molecular weight marker (50 bp ladder).Detection of partial AZFc deletion in an infertile male patient. A. The microdeletions observed were in Multiplex A (SY254 and
SY157) and B. In Multiplex C (SY255). Polymerase chain reaction (PCR) fragments were separated on a 3.5% agarose gel. Lane 1; Fertile
control, Lane 2; Infertile man, and Lane 3; Negative control. Multiplex A reaction contained SY81 (209 bp), SY130 (173 bp), SY157 (290
bp), SY182 (125 bp) and SY254 (380 bp), and multiplex C reaction contained SY121 (190 bp), SY128 (228 bp),
SY145 (143 bp) and SY255
(124 bp). Molecular weight marker (50 bp ladder).
Discussion
The AZF region was originally identified by Tiepolo and
Zuffardi (28). These microdeletions are thought to be pathogenetically
involved in some cases of male infertility who
have azoospermia or severe oligozoospermia (4). Although
chromosomal abnormalities in sperms of infertile men may
lead to RPL (29), microdeletions in the AZFc region of the
Y chromosome may have an important function in embryo
“competency” or in maintaining gestation. This has led to
Y-chromosome AZFc microdeletion testing in RPL cases
when no other explanation for RPL is known (7).The Y chromosome is extremely rich in repetitive sequences,
organized in amplicons forming eight palindromes.
Most of the genes deleted in infertile men are
located in the palindromic regions of the Yq and are exclusively
expressed in the testes (3, 13). Since AZF microdeletions
usually include more than one gene, the role of
a single AZF gene cannot be specified and thus unclear.
Gene-specific deletions removing a single gene has been
only reported in the AZFa region (30). In our study, a single
infertile man (2.5%) had microdeletion in the AZFc region
(partial AZFc deletions), which displays a lower frequency
of AZF microdeletions than other reports in Iran (5, 31-33).Y chromosome microdeletions were neither found in
the male partners of women experiencing RPL nor in
the control group. Although this finding is in agreement
with the results obtained by Ghorbian et al. (24),
it does not support the results of Soleimanian et al.
(27) who detected Y chromosome microdeletions in
male partners of women with RPL. This discrepancy
could be explained by the small sample size, which is a
limitation of the current study. In addition, differences
in genetic background of the population studied here
and the typing of different sets of STS used in different
studies may explain the differences in the frequency
of AZF microdeletions. Adjusted sample size and use
of identical sets of STS could lessen the variation in
results.
Conclusion
We showed Y chromosome microdeletions were not
associated with non-obstructive infertility and recurrent
pregnancy loss in our population study. Thus, this study is
not supporting to test for AZF microdeletions in these two
groups.
Table 1
Genotype-phenotype correlation of AZF regions (3, 18)
Deletion
Deletions are known to correspond to:
AZFa deletion
Complete AZFa deletions: severe testicular phenotype, SCOS and spermatogenic arrest
Partial AZFa deletions: extremely rare
AZFb deletion
Complete AZFb deletions: spermatogenic arrest
Partial AZFb deletions: variable phenotypes from hypospermatogenesis to SCOS extremely rare
AZFc deletion
Complete AZFc deletions: variable phenotype which may range from mild oligospermia to azoospermia and SCOS
Partial AZFc deletion
Variable phenotypes from hypospermatogenesis to the SCOS
AZFbc deletion
SCOS/spermatogenic arrest
AZFabc deletion
SCOS
AZF; Azoospermia factor and SCOS; Sertoli cell-only syndrome.
Authors: C Giachini; E Guarducci; G Longepied; S Degl'Innocenti; L Becherini; G Forti; M J Mitchell; C Krausz Journal: J Med Genet Date: 2005-06 Impact factor: 6.318